Literature DB >> 25855750

Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity.

Everett Clinton Smith1, James Brett Case2, Hervé Blanc3, Ofer Isakov4, Noam Shomron4, Marco Vignuzzi3, Mark R Denison5.   

Abstract

UNLABELLED: Coronaviruses (CoVs) are unique in encoding a 3'→5' exoribonuclease within nonstructural protein 14 (nsp14-ExoN) that is required for high-fidelity replication, likely via proofreading. nsp14 associates with the CoV RNA-dependent RNA polymerase (nsp12-RdRp), and nsp14-ExoN activity is enhanced by binding nsp10, a small nonenzymatic protein. However, it is not known whether nsp10 functions in the regulation of CoV replication fidelity. To test this, we engineered single and double alanine substitution mutations into the genome of murine hepatitis virus (MHV-A59) containing ExoN activity [ExoN(+)] at positions within nsp10 known to disrupt the nsp10-nsp14 interaction in vitro. We show that an nsp10 mutant, R80A/E82A-ExoN(+), was five to ten times more sensitive to treatment with the RNA mutagen 5-fluorouracil (5-FU) than wild-type (WT)-ExoN(+), suggestive of decreased replication fidelity. This decreased-fidelity phenotype was confirmed using two additional nucleoside analogs, 5-azacytidine and ribavirin. R80A/E82A-ExoN(+) reached a peak titer similar to and demonstrated RNA synthesis kinetics comparable to those seen with WT-ExoN(+). No change in 5-FU sensitivity was observed for R80A/E82A-ExoN(-) relative to MHV-ExoN(-), indicating that the decreased-fidelity phenotype of R80A/E82A-ExoN(-) is linked to the presence of ExoN activity. Our results demonstrate that nsp10 is important for CoV replication fidelity and support the hypothesis that nsp10 functions to regulate nsp14-ExoN activity during virus replication. IMPORTANCE: The adaptive capacity of CoVs, as well as all other RNA viruses, is partially attributed to the presence of extensive population genetic diversity. However, decreased fidelity is detrimental to CoV replication and virulence; mutant CoVs with decreased replication fidelity are attenuated and more sensitive to inhibition by RNA mutagens. Thus, identifying the viral protein determinants of CoV fidelity is important for understanding CoV replication, pathogenesis, and virulence. In this report, we show that nsp10, a small, nonenzymatic viral protein, contributes to CoV replication fidelity. Our data support the hypothesis that CoVs have evolved multiple proteins, in addition to nsp14-ExoN, that are responsible for maintaining the integrity of the largest known RNA genomes.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25855750      PMCID: PMC4474304          DOI: 10.1128/JVI.00110-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex.

Authors:  Mickaël Bouvet; Isabelle Imbert; Lorenzo Subissi; Laure Gluais; Bruno Canard; Etienne Decroly
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-25       Impact factor: 11.205

2.  Arbovirus high fidelity variant loses fitness in mosquitoes and mice.

Authors:  Lark L Coffey; Yasnee Beeharry; Antonio V Bordería; Hervé Blanc; Marco Vignuzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

3.  In vitro reconstitution of SARS-coronavirus mRNA cap methylation.

Authors:  Mickaël Bouvet; Claire Debarnot; Isabelle Imbert; Barbara Selisko; Eric J Snijder; Bruno Canard; Etienne Decroly
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

4.  The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent.

Authors:  Aartjan J W te Velthuis; Jamie J Arnold; Craig E Cameron; Sjoerd H E van den Worm; Eric J Snijder
Journal:  Nucleic Acids Res       Date:  2009-10-29       Impact factor: 16.971

Review 5.  Rationalizing the development of live attenuated virus vaccines.

Authors:  Adam S Lauring; Jeremy O Jones; Raul Andino
Journal:  Nat Biotechnol       Date:  2010-06-07       Impact factor: 54.908

6.  2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members.

Authors:  Stephane Daffis; Kristy J Szretter; Jill Schriewer; Jianqing Li; Soonjeon Youn; John Errett; Tsai-Yu Lin; Stewart Schneller; Roland Zust; Hongping Dong; Volker Thiel; Ganes C Sen; Volker Fensterl; William B Klimstra; Theodore C Pierson; R Mark Buller; Michael Gale; Pei-Yong Shi; Michael S Diamond
Journal:  Nature       Date:  2010-11-18       Impact factor: 49.962

7.  Molecular mapping of the RNA Cap 2'-O-methyltransferase activation interface between severe acute respiratory syndrome coronavirus nsp10 and nsp16.

Authors:  Adrien Lugari; Stephane Betzi; Etienne Decroly; Emmanuel Bonnaud; Aurélie Hermant; Jean-Claude Guillemot; Claire Debarnot; Jean-Paul Borg; Mickaël Bouvet; Bruno Canard; Xavier Morelli; Patrick Lécine
Journal:  J Biol Chem       Date:  2010-08-10       Impact factor: 5.157

8.  Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.

Authors:  Yu Chen; Ceyang Su; Min Ke; Xu Jin; Lirong Xu; Zhou Zhang; Andong Wu; Ying Sun; Zhouning Yang; Po Tien; Tero Ahola; Yi Liang; Xinqi Liu; Deyin Guo
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

9.  Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex.

Authors:  Etienne Decroly; Claire Debarnot; François Ferron; Mickael Bouvet; Bruno Coutard; Isabelle Imbert; Laure Gluais; Nicolas Papageorgiou; Andrew Sharff; Gérard Bricogne; Miguel Ortiz-Lombardia; Julien Lescar; Bruno Canard
Journal:  PLoS Pathog       Date:  2011-05-26       Impact factor: 6.823

10.  Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5.

Authors:  Roland Züst; Luisa Cervantes-Barragan; Matthias Habjan; Reinhard Maier; Benjamin W Neuman; John Ziebuhr; Kristy J Szretter; Susan C Baker; Winfried Barchet; Michael S Diamond; Stuart G Siddell; Burkhard Ludewig; Volker Thiel
Journal:  Nat Immunol       Date:  2011-01-09       Impact factor: 25.606

View more
  30 in total

1.  Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens.

Authors:  Nicole R Sexton; Everett Clinton Smith; Hervé Blanc; Marco Vignuzzi; Olve B Peersen; Mark R Denison
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

2.  Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex.

Authors:  Yuanyuan Ma; Lijie Wu; Neil Shaw; Yan Gao; Jin Wang; Yuna Sun; Zhiyong Lou; Liming Yan; Rongguang Zhang; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-09       Impact factor: 11.205

Review 3.  Emergency Services of Viral RNAs: Repair and Remodeling.

Authors:  Vadim I Agol; Anatoly P Gmyl
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-14       Impact factor: 11.056

4.  Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.

Authors:  Devendra K Rai; Fayna Diaz-San Segundo; Grace Campagnola; Anna Keith; Elizabeth A Schafer; Anna Kloc; Teresa de Los Santos; Olve Peersen; Elizabeth Rieder
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 5.  Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.

Authors:  Yuhang Wang; Matthew Grunewald; Stanley Perlman
Journal:  Methods Mol Biol       Date:  2020

6.  Mutagenesis of S-Adenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity.

Authors:  James Brett Case; Alison W Ashbrook; Terence S Dermody; Mark R Denison
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

7.  Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.

Authors:  Pramod R Bhatt; Alain Scaiola; Gary Loughran; Marc Leibundgut; Annika Kratzel; Romane Meurs; René Dreos; Kate M O'Connor; Angus McMillan; Jeffrey W Bode; Volker Thiel; David Gatfield; John F Atkins; Nenad Ban
Journal:  Science       Date:  2021-05-13       Impact factor: 63.714

Review 8.  The Baltimore Classification of Viruses 50 Years Later: How Does It Stand in the Light of Virus Evolution?

Authors:  Eugene V Koonin; Mart Krupovic; Vadim I Agol
Journal:  Microbiol Mol Biol Rev       Date:  2021-07-14       Impact factor: 13.044

9.  Viral Polymerase-Helicase Complexes Regulate Replication Fidelity To Overcome Intracellular Nucleotide Depletion.

Authors:  Kenneth A Stapleford; Kathryn Rozen-Gagnon; Pratyush Kumar Das; Sirle Saul; Enzo Z Poirier; Hervé Blanc; Pierre-Olivier Vidalain; Andres Merits; Marco Vignuzzi
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

10.  Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.

Authors:  Berta Canal; Allison W McClure; Joseph F Curran; Mary Wu; Rachel Ulferts; Florian Weissmann; Jingkun Zeng; Agustina P Bertolin; Jennifer C Milligan; Souradeep Basu; Lucy S Drury; Tom D Deegan; Ryo Fujisawa; Emma L Roberts; Clovis Basier; Karim Labib; Rupert Beale; Michael Howell; John F X Diffley
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.